niacinamide has been researched along with haloperidol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Halbhübner, K; Herken, H; Loos, D; Meyer-Estorf, G | 1 |
| Kadysheva, NM; Kryzhanovskiĭ, GN; Mokhovikov, AN; Mosketi, KV | 1 |
| Bai, T; Sun, Y; Wang, S; Wang, W; Zhao, Y; Zhu, R | 1 |
| Almeida, MC; de Lima, MO; Echeverry, MB; Prieto, SG; Silva, JCS | 1 |
6 other study(ies) available for niacinamide and haloperidol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Spastic paresis after 6-aminonicotinamide: metabolic disorders in the spinal cord and electromyographically recorded changes in the hind limbs of rats.
Topics: 6-Aminonicotinamide; Action Potentials; Animals; Baclofen; Brain; Chlorpromazine; Electromyography; Gluconates; Glucose-6-Phosphate Isomerase; Glycolysis; Haloperidol; Male; Muscle Spasticity; Muscles; Niacinamide; Phosphogluconate Dehydrogenase; Rats; Spinal Cord | 1976 |
[Comparative effectiveness of the combined use of fenazepam, haloperidol, lithium and metabolic preparations in treating the psychopathologic disorders with obsessions in slowly progressive schizophrenia].
Topics: Adolescent; Adult; Aged; alpha-Tocopherol; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Chronic Disease; Compulsive Personality Disorder; Drug Evaluation; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Male; Middle Aged; Niacinamide; Personality Disorders; Psychopathology; Pyridoxal Phosphate; Schizophrenia; Tocopherols; Vitamin E | 1988 |
Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Dose-Response Relationship, Drug; Haloperidol; Humans; Iron; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Receptors, sigma; Sigma-1 Receptor; Sorafenib; Structure-Activity Relationship; Tumor Cells, Cultured | 2017 |
Cross-tolerance between nitric oxide synthase inhibition and atypical antipsychotics modify nicotinamide-adenine-dinucleotide phosphate-diaphorase activity in mouse lateral striatum.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Catalepsy; Corpus Striatum; Enzyme Inhibitors; Haloperidol; Male; Mice; Mice, Inbred C57BL; NADP; NADPH Dehydrogenase; Niacinamide; Nitric Oxide Synthase; Nitroarginine; Proto-Oncogene Proteins c-fos | 2019 |